Publications by authors named "B P F Koene"
Article Synopsis
- The study reviews the rising trend of performing tricuspid valve repair alongside mitral valve surgery, exploring its impact on the risk of needing a permanent pacemaker post-surgery.
- A total of 1,060 patients were analyzed, showing an overall permanent pacemaker implantation rate of 4.3%, with no significant difference between those undergoing only mitral valve surgery and those having both mitral and tricuspid surgeries.
- Ultimately, the findings suggest that adding tricuspid valve surgery does not independently increase the risk of permanent pacemaker implantation after mitral valve surgery.
Purpose: To assess the diagnostic performance of prostate specific membranous antigen (PSMA) positron emission tomography/computed tomography (PET/CT) imaging to localize primary prostate cancer (PCa) in men with persistent elevated prostate-specific antigen (PSA) levels and previous prostate biopsies that were negative for PCa.
Methods: In this study, 34 men with persistently elevated PSA-levels, previous negative for PCa biopsies and who subsequently underwent diagnostic PSMA-PET/CT imaging were retrospectively evaluated. Men were divided into 3 groups: 1.
In prostate cancer (PCa) patients, the tumor-to-blood ratio (TBR) has been validated as the preferred simplified method for lesional F-DCFPyL (a radiolabeled prostate-specific membrane antigen ligand) uptake quantification on PET. In contrast to SUVs, the TBR accounts for variability in arterial input functions caused by differences in total tumor burden between patients (the sink effect). However, TBR depends strongly on tracer uptake interval and has worse repeatability and is less applicable in clinical practice than SUVs.
View Article and Find Full Text PDFBackground: The decision to implant a biological valve prosthesis is influenced by the issue of durability. We investigated the rate and the cause of reintervention in 3 different aortic valve bioprostheses.
Methods: The study included all patients who underwent aortic valve replacement with a biological valve prosthesis between October 2009 and December 2018.